Last Updated: August 3, 2026

POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Polyethylene Glycol 3350 And Electrolytes, and when can generic versions of Polyethylene Glycol 3350 And Electrolytes launch?

Polyethylene Glycol 3350 And Electrolytes is a drug marketed by Paddock Llc and Strides Pharma and is included in two NDAs.

The generic ingredient in POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and twenty-one drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES?
What are the global sales for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES?
What is Average Wholesale Price for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES?

Summary for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES

US Patents:	0
Applicants:	2
NDAs:	2

US Patents and Regulatory Information for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Paddock Llc	POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES	polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous	FOR SOLUTION;ORAL	090712-001	Feb 25, 2010		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Strides Pharma	POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES	polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous	FOR SOLUTION;ORAL	204558-001	Dec 21, 2018	AA	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.